S. Asenbaum

7.1k citations

105 papers · 5.1k indexed · h-index 42

Impact in

Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
Cellular and Molecular Neuroscience top 1%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
- Genetic Neurodegenerative Diseases

Papers in ⓘ

Biological Psychiatry 6
Cellular and Molecular Neuroscience 37
- Neurotransmitter Receptor Influence on Behavior 20
- Neuroscience and Neuropharmacology Research 14

Co-authors: Walter Pirker (26 shared papers)Thomas Brücke (24 shared papers)I. Podreka (28 shared papers)Siegfried Kasper (33 shared papers)J. Tauscher (27 shared papers)P. Angelberger (9 shared papers)Klaus Tatsch (10 shared papers)T. Br�cke (8 shared papers)
Journals: Biological Psychiatry (12 papers)European Neuropsychopharmacology (10 papers)Psychopharmacology (8 papers)Movement Disorders (6 papers)Journal of Neural Transmission (6 papers)
Partner nations: Austria Germany Sweden

In The Last Decade

S. Asenbaum

102 papers receiving 4.9k citations

Peers

Countries citing papers authored by S. Asenbaum

Since Specialization

Citations

This map shows the geographic impact of S. Asenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Asenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Asenbaum more than expected).

Fields of papers citing papers by S. Asenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Asenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Asenbaum. The network helps show where S. Asenbaum may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Asenbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Asenbaum Line = papers co-authored together S. Asenbaum links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2 European Journal of Nuclear Medicine and Molecular Imaging ·Andrea Varrone, S. Asenbaum, Thierry Vander Borght, Jan Booij, Flavio Nobili, Kjell Någren, Jacques Darcourt, Lütfiye Özlem Atay, Klaus Tatsch, Peter Bartenstein, Koen Van Laere	2009	410
2	European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis European Journal of Nuclear Medicine and Molecular Imaging ·Andrea Varrone, John Dickson, Livia Tossici-Bolt, Teréz Séra, S. Asenbaum, Jan Booij, Lütfiye Özlem Atay, Andreas Kluge, Gitte M. Knudsen, Pierre Malick Koulibaly, Flavio Nobili, Marco Pagani, Osama Sabri, Thierry Vander Borght, Koen Van Laere, Klaus Tatsch	2012	178
3	Brain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionine European Journal of Nuclear Medicine and Molecular Imaging ·Alexander Becherer, Georgios Karanikas, Monica Szab�, Georg Zettinig, S. Asenbaum, Christine Marosi, Christine B. Henk, Patrick Wunderbaldinger, Thomas Czech, Wolfgang Wadsak, Kurt Kletter	2003	176
4	Topographic distribution of sleep spindles in young healthy subjects Journal of Sleep Research ·J. Zeitlhofer, G. Gruber, P. Anderer, S. Asenbaum, P. Schimicek, B. Saletu	1997	176
5	5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement Cancer ·Georg Widhalm, Stefan Wolfsberger, Georgi Minchev, Adelheid Wöehrer, Martin Krššák, Thomas Czech, Daniela Prayer, S. Asenbaum, Johannes A. Hainfellner, Engelbert Knosp	2010	168
6	Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal β‐CIT SPECT study Movement Disorders ·Walter Pirker, S. Djamshidian, S. Asenbaum, Willibald Gerschlager, Gotthard G. Tribl, Martha Hoffmann, Thomas Brücke	2002	165
7	SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain Journal of Neural Transmission ·T. Br�cke, Johannes Kornhuber, P. Angelberger, S. Asenbaum, H. Frassine, I. Podreka	1993	161
8	[123I]?-CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration Movement Disorders ·Walter Pirker, S. Asenbaum, Gerhard Bencsits, Daniela Prayer, Willibald Gerschlager, L�der Deecke, T. Br�cke	2000	157
9	Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. PubMed ·Walter Pirker, S. Asenbaum, M Hauk, Susanne Kandlhofer, J. Tauscher, Matthäus Willeit, Alexander Neumeister, N. Praschak-Rieder, P. Angelberger, T. Brücke	2000	151
10	[123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder Biological Psychiatry ·Matthäus Willeit, N. Praschak-Rieder, Alexander Neumeister, Walter Pirker, S. Asenbaum, Oliver Vitouch, J. Tauscher, Eva Hilger, J. Stastny, Thomas Brücke, Siegfried Kasper	2000	143
11	[ 123 I]β-CIT and SPECT in essential tremor and Parkinson's disease Journal of Neural Transmission ·S. Asenbaum, Walter Pirker, P. Angelberger, Gerhard Bencsits, M. Pruckmayer, Thomas Brücke	1998	137
12	Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. PubMed ·Thomas Brücke, S. Asenbaum, Walter Pirker, S. Djamshidian, S. Wenger, Christian Wöber, Christian M. Müller, I. Podreka	1997	135
13	Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease. PubMed ·S. Asenbaum, Thomas Brücke, Walter Pirker, I. Podreka, P. Angelberger, S. Wenger, Christian Wöber, F. Max Müller, L. Deecke	1997	129
14	[123I] β-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa Biological Psychiatry ·J. Tauscher, Walter Pirker, Matthäus Willeit, Martina de Zwaan, Ursula F. Bailer, Alexander Neumeister, S. Asenbaum, C. Lennkh, N. Praschak-Rieder, Thomas Brücke, Siegfried Kasper	2001	108
15	No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism Biological Psychiatry ·Matthäus Willeit, J. Stastny, Walter Pirker, N. Praschak-Rieder, Alexander Neumeister, S. Asenbaum, J. Tauscher, Karoline Fuchs, Werner Sieghart, Kurt Hornik, H.N. Aschauer, Thomas Brücke, Siegfried Kasper	2001	104
16	?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo Journal of Neural Transmission ·Walter Pirker, S. Asenbaum, Siegfried Kasper, H. Walter, P. Angelberger, Gustavo Duarte Waltereith Koch, A. Pozzera, L. Deecke, I. Podreka, T. Br�cke	1995	101
17	[¹²³I]β‐CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease Movement Disorders ·Willibald Gerschlager, Gerhard Bencsits, Walter Pirker, Bastiaan R. Bloem, S. Asenbaum, D. Prayer, Jan Zijlmans, Martha Hoffmann, Thomas Brücke	2002	84
18	Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls Psychological Medicine ·Alexander Neumeister, Matthäus Willeit, N. Praschak-Rieder, S. Asenbaum, J. Stastny, Eva Hilger, Walter Pirker, Anastasios Konstantinidis, Siegfried Kasper	2001	82
19	EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues European Journal of Nuclear Medicine and Molecular Imaging ·Thierry Vander Borght, S. Asenbaum, P. Bartenstein, Christer Halldin, (unknown), Koen Van Laere, Andrea Varrone, Klaus Tatsch	2006	76
20	Receptor and Transporter Imaging Studies in Schizophrenia, Depression, Bulimia and Tourette's Disorder—Implications for Psychopharmacology- The World Journal of Biological Psychiatry ·Siegfried Kasper, J. Tauscher, Matthäus Willeit, M. Stamenković, Alexander Neumeister, B. Küfferle, Christian Barnas, J. Stastny, N. Praschak-Rieder, Lukas Pezawas, Martina de Zwaan, Sylvia Quiner, Walter Pirker, S. Asenbaum, I. Podreka, Thomas Brücke	2002	72

About S. Asenbaum

S. Asenbaum is a scholar working on Biological Psychiatry, Cellular and Molecular Neuroscience, Neurology, Psychiatry and Mental health and Radiology, Nuclear Medicine and Imaging, having authored 105 papers that have together received 5.1k indexed citations. Recurring topics across this work include Neurological disorders and treatments (20 papers), Neurotransmitter Receptor Influence on Behavior (20 papers), Parkinson's Disease Mechanisms and Treatments (17 papers), Medical Imaging Techniques and Applications (16 papers), Neuroscience and Neuropharmacology Research (14 papers), Schizophrenia research and treatment (14 papers), Treatment of Major Depression (11 papers) and Electroconvulsive Therapy Studies (10 papers). The work is most often cited by research in Neurology (1.9k citations), Cellular and Molecular Neuroscience (1.7k citations), Psychiatry and Mental health (964 citations), Biological Psychiatry (145 citations) and Cognitive Neuroscience (928 citations). S. Asenbaum has collaborated with scholars based in Austria, Germany and Sweden. Frequent co-authors include Walter Pirker, Thomas Brücke, I. Podreka, Siegfried Kasper, J. Tauscher, P. Angelberger, Klaus Tatsch, T. Br�cke, Matthäus Willeit and Alexander Neumeister. Their work appears in journals such as Biological Psychiatry, European Neuropsychopharmacology, Psychopharmacology, Movement Disorders and Journal of Neural Transmission.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact